文献速递甲状腺疾病

孕前启动甲状腺功能减退症治疗对儿童神经认知功能的影响

Impact of Preconception Treatment Initiation for Hypothyroidism on Neurocognitive Function in Children.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

这项前瞻性单中心队列研究在三级医院纳入466名女性,按甲状腺功能减退症诊断和治疗时间分为孕前组(187例)和孕后组(279例,孕8-14周),均接受左甲状腺素治疗并根据每月甲状腺功能检测调整。儿童6、12、24月龄采用中文版Gesell发育诊断量表评估,孕前组在12月龄运动能力和总分、24月龄适应性上意外略低,亚临床甲状腺功能减退症亚组分析中运动能力和总分差异持续存在;孕前治疗并未比孕8-14周启动治疗带来显著更好的认知结局。

要点

  • 孕前左甲状腺素治疗与孕8-14周启动治疗相比,儿童2岁内认知结局无显著差异。
  • 孕前组12月龄运动能力(P=.009)和总分(P=.026)、24月龄适应性(P=.037)意外略低。
  • 亚临床甲状腺功能减退症亚组中,运动能力(P<.001)和总分(P=.026)差异持续存在。

核心结论

  • 孕前左甲状腺素治疗并未比孕8-14周启动治疗带来显著更好的2岁内儿童认知结局。

研究设计与样本

  • 前瞻性单中心队列研究,在三级医院开展,纳入466名女性,孕前组187例、孕后组279例。

主要发现

  • 两组基线产检时可比,但孕前组甲状腺过氧化物酶(TPO)抗体阳性比例更高(P<.001)。
  • 6、12、24月龄Gesell发育诊断量表评估多数无显著组间差异(P>.05)。
  • 孕前组12月龄运动能力(P=.009)和总分(P=.026)略低,24月龄适应性略低(P=.037)。
  • 亚临床甲状腺功能减退症亚组分析中,运动能力(P<.001)和总分(P=.026)差异持续存在。
  • 按严重程度和TPO状态分析,妊娠和新生儿结局无显著差异(P>.05)。

关键数值与推荐

  • 主要结局为Gesell发育诊断量表总分。
  • 孕后组在孕8-14周启动治疗。
  • 左甲状腺素剂量根据每月甲状腺功能检测结果调整。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Levothyroxine treatment for hypothyroidism in early pregnancy has inconsistent outcomes. OBJECTIVE: This study evaluated children's cognitive function to ascertain the impact of preconception maternal hypothyroidism treatment on fetal neurodevelopment. DESIGN AND SETTING: This prospective, single-center cohort study was conducted at a tertiary-care hospital. PATIENTS: Women were assigned to the before conception (BC) and after conception (AC; 8-14 gestational weeks) groups by time point of hypothyroidism diagnosis and treatment. INTERVENTIONS: Levothyroxine treatment was adjusted based on results of a monthly thyroid function test. MAIN OUTCOME MEASURES: The Gesell Development Diagnosis Scale (GDDS; Chinese version) was used to assess neurocognitive development of children at age 6, 12, and 24 months, with total score as the primary outcome. RESULTS: Of the 466 participants, 187 and 279 were in the BC and AC groups, respectively. Both groups were comparable at baseline antenatal visit, except for a higher proportion of thyroid peroxidase (TPO) antibody-positive participants in the BC group (P < .001). No significant intergroup differences were evident on the GDDS neurodevelopmental assessment at age 6, 12, and 24 months (P > .05), except for unexpected slightly lower motor ability (P = .009) and total (P = .026) scores at 12 months and adaptability at 24 months (P = .037) in the BC group. Differences for motor ability (P < .001) and total score (P = .026) persisted on subgroup analysis for subclinical hypothyroidism, without significant differences in pregnancy and neonatal outcomes by severity and TPO status (P > .05). CONCLUSIONS: Preconception levothyroxine treatment did not induce significantly better cognitive outcomes in children up to age 2 than treatment initiated at 8 to 14 weeks of gestation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhou Q, Wang C, Xu H, et al. Impact of Preconception Treatment Initiation for Hypothyroidism on Neurocognitive Function in Children. J Clin Endocrinol Metab. 2020. PMID: 32841335. doi:10.1210/clinem/dgaa565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。